![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ERG28 |
Gene summary for ERG28 |
![]() |
Gene information | Species | Human | Gene symbol | ERG28 | Gene ID | 11161 |
Gene name | ergosterol biosynthesis 28 homolog | |
Gene Alias | C14orf1 | |
Cytomap | 14q24.3 | |
Gene Type | protein-coding | GO ID | GO:0006629 | UniProtAcc | Q6FII3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
11161 | ERG28 | S014 | Human | Liver | HCC | 1.92e-59 | 1.88e+00 | 0.2254 |
11161 | ERG28 | S015 | Human | Liver | HCC | 7.07e-56 | 2.06e+00 | 0.2375 |
11161 | ERG28 | S016 | Human | Liver | HCC | 1.55e-66 | 1.86e+00 | 0.2243 |
11161 | ERG28 | S027 | Human | Liver | HCC | 2.14e-11 | 6.46e-01 | 0.2446 |
11161 | ERG28 | S028 | Human | Liver | HCC | 3.90e-32 | 8.27e-01 | 0.2503 |
11161 | ERG28 | S029 | Human | Liver | HCC | 8.02e-40 | 1.21e+00 | 0.2581 |
11161 | ERG28 | male-WTA | Human | Thyroid | PTC | 1.46e-36 | 4.61e-01 | 0.1037 |
11161 | ERG28 | female-WTA | Human | Thyroid | PTC | 2.08e-02 | 2.38e-01 | 0.0726 |
11161 | ERG28 | nodule-WTA | Human | Thyroid | goiters | 1.25e-04 | 2.52e-01 | 0.0534 |
11161 | ERG28 | PTC01 | Human | Thyroid | PTC | 6.03e-40 | 7.57e-01 | 0.1899 |
11161 | ERG28 | PTC03 | Human | Thyroid | PTC | 9.50e-07 | 3.38e-01 | 0.1784 |
11161 | ERG28 | PTC04 | Human | Thyroid | PTC | 7.43e-16 | 3.47e-01 | 0.1927 |
11161 | ERG28 | PTC05 | Human | Thyroid | PTC | 3.34e-30 | 9.68e-01 | 0.2065 |
11161 | ERG28 | PTC06 | Human | Thyroid | PTC | 1.09e-48 | 9.55e-01 | 0.2057 |
11161 | ERG28 | PTC07 | Human | Thyroid | PTC | 5.60e-61 | 1.03e+00 | 0.2044 |
11161 | ERG28 | ATC08 | Human | Thyroid | ATC | 8.31e-05 | 2.10e-01 | 0.0541 |
11161 | ERG28 | ATC11 | Human | Thyroid | ATC | 1.60e-07 | 5.69e-01 | 0.3386 |
11161 | ERG28 | ATC12 | Human | Thyroid | ATC | 4.25e-14 | 2.96e-01 | 0.34 |
11161 | ERG28 | ATC13 | Human | Thyroid | ATC | 2.29e-02 | 1.17e-01 | 0.34 |
11161 | ERG28 | ATC2 | Human | Thyroid | ATC | 4.44e-15 | 8.79e-01 | 0.34 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0008202 | Colorectum | AD | steroid metabolic process | 85/3918 | 319/18723 | 8.07e-03 | 4.75e-02 | 85 |
GO:00161263 | Esophagus | ESCC | sterol biosynthetic process | 46/8552 | 64/18723 | 1.91e-05 | 1.67e-04 | 46 |
GO:00066946 | Esophagus | ESCC | steroid biosynthetic process | 98/8552 | 173/18723 | 2.34e-03 | 1.03e-02 | 98 |
GO:00161254 | Esophagus | ESCC | sterol metabolic process | 86/8552 | 152/18723 | 4.37e-03 | 1.73e-02 | 86 |
GO:19016174 | Esophagus | ESCC | organic hydroxy compound biosynthetic process | 128/8552 | 237/18723 | 5.86e-03 | 2.16e-02 | 128 |
GO:00082022 | Liver | HCC | steroid metabolic process | 188/7958 | 319/18723 | 1.96e-09 | 5.63e-08 | 188 |
GO:00161252 | Liver | HCC | sterol metabolic process | 101/7958 | 152/18723 | 1.99e-09 | 5.63e-08 | 101 |
GO:00161261 | Liver | HCC | sterol biosynthetic process | 47/7958 | 64/18723 | 5.00e-07 | 8.11e-06 | 47 |
GO:00066942 | Liver | HCC | steroid biosynthetic process | 104/7958 | 173/18723 | 2.13e-06 | 2.91e-05 | 104 |
GO:19016172 | Liver | HCC | organic hydroxy compound biosynthetic process | 129/7958 | 237/18723 | 1.32e-04 | 1.08e-03 | 129 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |